This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Kureha Corporation, Seikagaku Corporation. Active years: 2013-2023.
Company Filing History:
Years Active: 2013-2023
Title: Hirotaka Hoshi: Innovator in Pharmaceutical Composition
Introduction
Hirotaka Hoshi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compositions for treating various medical conditions. With a total of 2 patents, Hoshi's work is recognized for its potential impact on healthcare.
Latest Patents
Hoshi's latest patents include a pharmaceutical composition containing a hyaluronic acid derivative. This invention provides a method for suppressing the generation of diclofenac lactam from a specific compound. The method involves allowing the compound to coexist with various components, including nonionic surfactants and polyvinylpyrrolidone. Another significant patent focuses on a pharmaceutical composition for the treatment of cancer and asthma. This composition comprises a siRNA molecule that targets the mRNA of mucin subtype 5 AC, offering an efficient treatment for diseases associated with its overexpression, particularly pancreatic cancer and asthma.
Career Highlights
Throughout his career, Hirotaka Hoshi has worked with prominent companies such as Seikagaku Corporation and Kureha Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Hoshi has collaborated with notable coworkers, including Chiaki Takahata and Motoyuki Uchida. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Hirotaka Hoshi's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical treatments. His innovative patents reflect a deep understanding of complex biological processes and a dedication to improving patient outcomes.